OTCMKTS:PCLOF PharmaCielo (PCLOF) Stock Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free PCLOF Stock Alerts $0.12 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.11▼$0.1250-Day Range$0.09▼$0.2152-Week Range$0.08▼$0.22Volume3,150 shsAverage Volume11,414 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get PharmaCielo alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About PharmaCielo Stock (OTCMKTS:PCLOF)PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.Read More PCLOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PCLOF Stock News HeadlinesApril 24, 2024 | americanbankingnews.comPharmaCielo (OTCMKTS:PCLOF) Stock Price Down 4.7%April 10, 2024 | msn.comThis Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation LandscapeApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 10, 2024 | msn.comPharmaCielo signs binding letter of intent to acquire operations in ThailandFebruary 14, 2024 | msn.comCan Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes GlobalJanuary 4, 2024 | benzinga.comCannabis Companies Partner To Provide Seed-to-Pharma Products GloballyJanuary 4, 2024 | finance.yahoo.comBenuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related ProductsNovember 30, 2023 | benzinga.comPharmaCielo Stock (OTC:PCLOF), Short Interest ReportApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.November 30, 2023 | benzinga.comPharmaCielo Stock (OTC:PCLOF) Earnings Dates and Earning CallsNovember 29, 2023 | msn.comPharmaCielo GAAP EPS of -C$0.02, revenue of C$352MNovember 29, 2023 | finanznachrichten.dePharmaCielo Ltd.: PharmaCielo Announces Q3 2023 Financial ResultsNovember 29, 2023 | finance.yahoo.comPharmaCielo Announces Q3 2023 Financial ResultsNovember 8, 2023 | morningstar.comPharmaCielo Ltd Ordinary Shares PCLOFOctober 6, 2023 | finanznachrichten.dePharmaCielo Ltd.: PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private PlacementOctober 6, 2023 | finance.yahoo.comPharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private PlacementAugust 29, 2023 | benzinga.comPharmaCielo Q2 2023 Results: Revenue Drops But CEO Is Optimistic About Future GrowthAugust 29, 2023 | finance.yahoo.comPharmaCielo Announces Q2 2023 Financial ResultsJuly 13, 2023 | msn.comPharmaCielo appoints Marc Lustig as chairman and CEOJuly 11, 2023 | finance.yahoo.comPharmaCielo Announces Appointment of Marc Lustig as Chairman and CEOMay 29, 2023 | finance.yahoo.comPharmaCielo Announces Q1 2023 Financial ResultsApril 19, 2023 | finance.yahoo.comPharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis MarketFebruary 24, 2023 | finance.yahoo.comPharmaCielo Ltd. (PCLOF) Stock Historical Prices & Data - Yahoo FinanceFebruary 2, 2023 | finance.yahoo.comPharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant TermsJanuary 30, 2023 | finance.yahoo.comPharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian MarketDecember 5, 2022 | finance.yahoo.comPharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in MoroccoNovember 22, 2022 | finance.yahoo.comPharmaCielo Announces TSX Venture Exchange Approval of Warrant ExtensionSee More Headlines Receive PCLOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmaCielo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Next Earnings (Estimated)5/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:PCLOF CUSIPN/A CIKN/A Webwww.pharmacielo.com Phone(416) 562-3220FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Chairman & CEO Comp: $41.76kMr. Ian D. Atacan B.Sc.C.M.A., C.P.A., M.B.A., CFO, Corporate Secretary & DirectorMr. Andres Felipe BoteroChief Operating OfficerDr. Decio Rabelo de Castro FilhoChief Medical OfficerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors PCLOF Stock Analysis - Frequently Asked Questions How have PCLOF shares performed in 2024? PharmaCielo's stock was trading at $0.1290 on January 1st, 2024. Since then, PCLOF shares have decreased by 10.9% and is now trading at $0.1150. View the best growth stocks for 2024 here. When is PharmaCielo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024. View our PCLOF earnings forecast. How do I buy shares of PharmaCielo? Shares of PCLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PCLOF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCielo Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
